A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient evidence that a drug called pomalidomide, which is used to treat bone marrow ...
A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare but devastating bleeding disorder. Hereditary ...
Atavistik Bio is led by an experienced team of drug hunters with a proven track record of developing marketed small molecule therapies and supported by top-tier investors, including The Column Group, ...
MANHASSET, N.Y.--(BUSINESS WIRE)--To research new treatments for Hereditary hemorrhagic telangiectasia (HHT) – a genetic bleeding disorder in which blood vessels do not form properly– the National ...
Kate James suffered from nosebleeds her entire life, but she didn't think too much of them. It wasn't until one of her children threw up blood that she finally got an HHT diagnosis. Kate and two of ...
MONKTON, Md., June 15, 2020 /PRNewswire-PRWeb/ -- Cure HHT, the only patient advocacy organization in the world funding research, awareness and education for the rare genetic disease HHT for patients, ...
Bevacizumab has shown efficacy in the treatment of hereditary hemorrhagic telangiectasia (HHT), a rare, progressive bleeding disorder for which there are currently no approved therapies. The finding ...
Vaderis Therapeutics’ goal to develop the first drug aimed specifically at a certain rare blood vessel disorder came one step closer today with the news that the therapy is safe and reduced nosebleeds ...
People with HHT have a near-typical life expectancy as long as they follow their treatment plan and undergo regular screening for complications. Hereditary hemorrhagic telangiectasia (HHT) is a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback